as on November 7, 2025 at 10:37 pm IST
Day's Low
Day's High
1.85%
Downside
2.81%
Upside
52 Week's Low
52 Week's High
57.40%
Downside
19.25%
Upside
Check Protagonist Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$4.8B
EPS (TTM)
-2.0375
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
3.51%
PE Ratio (TTM)
106.68
Industry PE ratio
8.355964912280701
PEG Ratio
0EBITDA
24.9M
Revenue (TTM)
209.2M
Profit Margin
24.88%
Return On Equity TTM
8.61%
Track how Protagonist Therapeutics Inc P/E has moved over time to understand its valuation trends.
Protagonist Therapeutics Inc in the last 5 years
Lowest (-17.69x)
September 30, 2021
Industry (8.36x)
November 7, 2025
Today (106.68x)
November 7, 2025
Highest (68.56x)
June 30, 2025
Today’s Price to Earnings Ratio: 106.68x
Compare market cap, revenue, PE, and other key metrics of Protagonist Therapeutics Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $4.8B | 274.91% | 106.68 | 24.88% | |
| BUY | $39.6B | 470.1% | -16.34 | -264.83% | |
| BUY | $57.4B | 236.95% | 1448.53 | 1.36% | |
| BUY | $105.8B | 88.96% | 29.32 | 31.35% | |
| BUY | $67.7B | 11.91% | 15.43 | 32.13% |
The Protagonist Therapeutics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Protagonist Therapeutics Inc investment value today
Current value as on today
₹1,69,358
Returns
₹69,358
(+69.36%)
Returns from Protagonist Therapeutics Inc Stock
₹64,251 (+64.25%)
Dollar Returns*
₹5,107 (+5.11%)
Based on 12 analysts
91.67%
Buy
8.33%
Hold
0.00%
Sell
Based on 12 analysts, 91.67% of analysts recommend a 'BUY' rating for Protagonist Therapeutics Inc. Average target price of $80.69
Get share price movements and forecasts by analysts on Protagonist Therapeutics Inc.
What analysts predicted
3.09%UPSIDE
Target Price
$80.69
Current Price
$78.2
Analyzed by
12 Analysts
Target
$80.69
Protagonist Therapeutics Inc target price $80.69, a slight upside of 3.09% compared to current price of $78.2. According to 12 analysts rating.
Search interest for Protagonist Therapeutics Inc Stock has increased by 889% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:889% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Today's Timeline - 13 October
Mon, 07:35 PM
-Johnson & Johnson reportedly in talks to acquire Protagonist Therapeutics, enhancing their collaboration on immunology treatments.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Price Rise
![]()
In the last 3 years, PTGX stock has moved up by 929.4%
Best in 3 Years
![]()
In the last 3 years, PTGX has outperformed top 5 stocks with highest market-cap in its industry
Against Peers
![]()
In the last 1 year, Insmed Incorporated has given 159.0% return, outperforming this stock by 91.4%
| Organisation | Protagonist Therapeutics Inc |
| Headquarters | 7707 Gateway Boulevard, Newark, CA, United States, 94560 |
| Industry | Health Technology |
| CEO | Dr. Dinesh V. Patel Ph.D. |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Dr. Dinesh V. Patel Ph.D. | CEO, President, Secretary & Director |
Mr. Asif Ali | Executive VP & CFO |
Ms. Carena Spivey | Senior VP & Chief Human Resources Officer |
Mr. Carter J. King | Executive Vice President of Business Development |
Dr. Ashok Bhandari Ph.D. | EVP & Chief Discovery Officer |
Dr. Suneel K. Gupta Ph.D. | Executive Vice President of Clinical Development |
Dr. Arturo M. Molina FACP, M.D., M.S. | Chief Medical Officer |
Mr. Mohammad Masjedizadeh Ph.D. | Executive VP & CTO |
Dr. Newman Yeilding | Executive VP, Chief Scientific Officer |
Mr. Matthew M. Gosling J.D. | Executive VP and Chief Legal & Business Officer |
Protagonist Therapeutics Inc share price today is $78.2 as on . Protagonist Therapeutics Inc share today touched a day high of $80.4 and a low of $76.75.
Protagonist Therapeutics Inc share touched a 52 week high of $93.25 on and a 52 week low of $33.31 on . Protagonist Therapeutics Inc stock price today i.e. is trending at $78.2,which is 16.14% down from its 52 week high and 134.76% up from its 52 week low.
Protagonist Therapeutics Inc market capitalisation is $0.00T as on .
Indian investors can start investing in Protagonist Therapeutics Inc (PTGX) shares with as little as ₹88.626 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹886.26 in Protagonist Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Protagonist Therapeutics Inc share’s latest price of $78.2 as on November 7, 2025 at 10:37 pm IST, you will get 0.1279 shares of Protagonist Therapeutics Inc. Learn more about
fractional shares .
Protagonist Therapeutics Inc stock has given 274.91% share price returns and 19.94% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?